Lymphocyte-Mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-Conspiracy

Por Payne, Kyle K.
Publicado no Immunol Invest (2016)

Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems

Por Manjili, Masoud H., Payne, Kyle K.
Publicado em 2012

Estrogens drive myeloid-derived suppressor cell accumulation

Por Conejo-Garcia, Jose R., Payne, Kyle K., Svoronos, Nikolaos
Publicado no Oncoscience (2017)

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma

Por Gowda, Madhu, Payne, Kyle K, Godder, Kamar, Manjili, Masoud H
Publicado em 2013

IFN-γ Rα Is a Key Determinant of CD8+ T Cell-Mediated Tumor Elimination or Tumor Escape and Relapse in FVB Mouse

Por Kmieciak, Maciej, Payne, Kyle K., Wang, Xiang-Yang, Manjili, Masoud H.
Publicado em 2013

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk

Por Payne, Kyle K., Toor, Amir A., Wang, Xiang-Yang, Manjili, Masoud H.
Publicado em 2012

IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape and progression

Por Aqbi, Hussein F., Wallace, Matthew, Sappal, Samay, Payne, Kyle K, Manjili, Masoud H
Publicado no J Leukoc Biol (2018)

Conditioning neoadjuvant therapies for improved immunotherapy of cancer

Por Benson, Zachary, Manjili, Saeed H., Habibi, Mehran, Guruli, Georgi, Toor, Amir A, Payne, Kyle K., Manjili, Masoud H.
Publicado no Biochem Pharmacol (2017)

Immunotherapy for Breast Cancer: Current and Future Strategies

Por Williams, Austin D., Payne, Kyle K., Posey, Avery D., Hill, Christine, Conejo-Garcia, Jose, June, Carl H., Tchou, Julia
Publicado no Curr Surg Rep (2017)

DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer

Por Terracina, Krista P., Graham, Laura J., Payne, Kyle K., Manjili, Masoud H., Baek, Annabel, Damle, Sheela R., Bear, Harry D.
Publicado no Cancer Immunol Immunother (2016)

Activated NK T cells and NK cells render T cells resistant to MDSC and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse

Por Kmieciak, Maciej, Basu, Debasmita, Payne, Kyle K, Toor, Amir, Yacoub, Adly, Wang, Xiang-Yang, Smith, Lisa, Bear, Harry D, Manjili, Masoud H
Publicado em 2011

Coordinated Upregulation of Mitochondrial Biogenesis and Autophagy in Breast Cancer Cells: The Role of Dynamin Related Protein-1 and Implication for Breast Cancer Treatment

Por Zou, Peng, Liu, Longhua, Zheng, Louise D., Payne, Kyle K., Manjili, Masoud H., Idowu, Michael O., Zhang, Jinfeng, Schmelz, Eva M., Cheng, Zhiyong
Publicado no Oxid Med Cell Longev (2016)

Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

Por Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, Latif, Bear, Harry D, Manjili, Masoud H
Publicado em 2013

Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

Por Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, A Latif, Bear, Harry D, Manjili, Masoud H
Publicado no Breast Cancer Res Treat (2013)

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells

Por Payne, Kyle K., Keim, Rebecca C., Graham, Laura, Idowu, Michael O., Wan, Wen, Wang, Xiang-Yang, Toor, Amir A., Bear, Harry D., Manjili, Masoud H.
Publicado no J Leukoc Biol (2016)

EXOSOMES PRODUCED BY MESENCHYMAL STEM CELLS DRIVE DIFFERENTIATION OF MYELOID CELLS INTO IMMUNOSUPPRESSIVE M2-POLARIZED MACROPHAGES IN BREAST CANCER

Por Biswas, Subir, Mandal, Gunjan, Chowdhury, Sougata Roy, Purohit, Suman, Payne, Kyle K., Anadon, Carmen, Gupta, Arnab, Swanson, Patricia, Yu, Xiaoqing, Conejo-Garcia, José R., Bhattacharyya, Arindam
Publicado no J Immunol (2019)

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure

Por Kmieciak, Maciej, Payne, Kyle K, Idowu, Michael O, Grimes, Margaret M, Graham, Laura, Ascierto, Maria-Libera, Wang, Ena, Wang, Xiang-Yang, Bear, Harry D, Manjili, Masoud H
Publicado em 2011

Gr1(−/low)CD11b(−/low)MHCII(+) myeloid cells boost T cell anti‐tumor efficacy

Por Payne, Kyle K., Aqbi, Hussein F., Butler, Savannah E., Graham, Laura, Keim, Rebecca C., Wan, Wen, Idowu, Michael O., Bear, Harry D., Wang, Xiang‐Yang, Manjili, Masoud H.
Publicado no J Leukoc Biol (2018)

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment

Por Perales-Puchalt, Alfredo, Svoronos, Nikolaos, Villarreal, Daniel O., Zankharia, Urvi, Reuschel, Emma, Wojtak, Krzysztof, Payne, Kyle K., Duperret, Elizabeth K., Muthumani, Kar, Conejo-Garcia, Jose R., Weiner, David B.
Publicado no Oncoimmunology (2018)

TRAMETINIB DRIVES T CELL-DEPENDENT CONTROL OF K-RAS-MUTATED TUMORS BY INHIBITING PATHOLOGICAL MYELOPOIESIS

Por Allegrezza, Michael J., Rutkowski, Melanie R., Stephen, Tom L., Svoronos, Nikolaos, Perales-Puchalt, Alfredo, Nguyen, Jenny M., Payne, Kyle K., Singhal, Sunil, Eruslanov, Evgeniy B., Tchou, Julia, Conejo-Garcia, Jose R.
Publicado no Cancer Res (2016)